Digitization of processes and data across the value chain along with the emergence of Internet of Things (IoT) has transformed the Pharma industry. Although IoT is still in its nascent stages of adoption in the Life Sciences industry, the use of smart devices and machine-to-machine (M2M) communication leveraging SMAC technologies comes at a time when the industry is grappling with patent cliffs and declining R&D productivity
In the pharma industry today, speed plays an important role as drug patent life is only 20 years and organizations have a short window to earn ROI. As a result, demands are enormous for innovative technology solutions that garner quick and smart results.
Read about the opportunities and challenges when the vastly underserved healthcare market, combined with high mobile phone penetration and rapidly growing smartphone adoption creates ideal conditions for mHealth adoption.
With a growing focus on the patient in the form of personalised medicine and services – rather than products – big data plays an important role in harnessing the information necessary for such a shift
Big data enabled consolidation and collaboration among different internal and external healthcare stakeholders will benefit pharma companies by breaking the silos that separate internal functions and enhance integrated, consistent research and care management.
An unprecedented rise of the failing M&A's has resulted in enormous financial and operational losses. Data Lakes has successfully addressed the problem by offering flexible data options for real time reporting,application integration and simplifying information systems.
What are your views on the social strategies that life sciences companies should adopt? Have you come across an interesting example of social engagement from a life sciences company?
A ready reckoner on how blockchain is eliminating occurrences of degraded temperature sensitive drugs due to broken cold chain logistics
Speed in taking much needed vaccines and drugs to market was never as important as now. With the novel Coronavirus (COVID-19) pandemic threatening casualties en-masse, speed of clinical research is a matter of life and death.
The purpose of this paper is to describe the importance of Risk Analysis, Risk Management Process, Application of Risk Management tools, and the benefit of the Risk Management Analysis.
How sustainable growth through innovation and market repositioning can drive the MedTech industry in India forward
The need for “plug-and-play” interoperability – the ability to take a medical device out of its box and easily make it work with one’s other devices or applications– has attracted great attention from both healthcare providers and industry.
Medical devices companies weave new business models to provide value-added services
Explore how M2M enables proactive service, allows for consumption-based business models and drives recurring revenue and improved customer experience
Revitalizing innovation for a Leading Medical Technology Company
Value engineered infusion pump
Streamlining and standardizing processes
The client is a premier global healthcare company with a turnover of over 17 billion dollars, delivering the highest quality care to people with renal and other chronic health conditions.